scanX
Home
Godavari Drugs

Godavari Drugs

104.00
+1.25
(1.22%)
Market Cap
78.34
Eps
7.37
PE Ratio (TTM)
11.60
Dividend Yield
0.00
Industry
Healthcare
52 Week High
155.00
52 Week low
86.99
PB Ratio
1.86
Debt to Equity
1.29
Sector
Pharmaceuticals
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-1.87 %
Net Income Growth
44.74 %
Cash Flow Change
39.26 %
ROE
25.68 %
ROCE
20.84 %
EBITDA Margin (Avg.)
34.09 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
55
71
76
65
84
96
123
161
160
157
141
Expenses
49
67
70
60
78
90
113
150
150
143
126
EBITDA
6
5
6
5
6
6
10
12
11
14
15
Operating Profit %
11 %
6 %
7 %
6 %
7 %
6 %
8 %
7 %
6 %
8 %
10 %
Depreciation
1
1
1
1
1
1
1
2
2
2
2
Interest
1
2
3
2
3
3
3
3
4
5
5
Profit Before Tax
5
2
3
1
2
2
6
7
5
7
8
Tax
1
1
1
1
1
0
2
2
1
1
1
Net Profit
4
1
2
1
1
2
4
5
4
6
7
EPS in ₹
4.84
1.79
2.40
1.10
1.60
2.66
5.48
6.97
5.03
7.37
8.80
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
35
51
56
63
74
84
91
101
121
135
Fixed Assets
7
9
13
15
15
14
22
26
25
27
Current Assets
27
40
43
47
57
61
68
74
87
89
Capital Work in Progress
0
1
0
1
2
9
1
1
9
18
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
27
41
43
48
57
61
68
75
87
90
Total Liabilities
35
51
56
63
74
84
91
101
121
135
Current Liabilities
17
31
34
37
46
51
51
58
74
82
Non Current Liabilities
5
5
6
9
9
12
16
14
14
14
Total Equity
13
14
16
17
18
20
24
30
33
39
Reserve & Surplus
6
7
9
10
11
13
17
22
26
31
Share Capital
8
8
8
8
8
8
8
8
8
8
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
1
-0
-0
0
1
1
-1
Investing Activities
-0
-2
-3
-3
-2
-7
-1
-5
-9
-13
Operating Activities
-6
-5
5
4
4
6
1
11
13
18
Financing Activities
6
7
-2
-0
-2
0
0
-6
-4
-6
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
55.86 %
56.13 %
56.13 %
56.13 %
56.36 %
56.92 %
56.92 %
53.12 %
53.12 %
53.16 %
53.16 %
53.16 %
53.16 %
53.16 %
52.63 %
52.63 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
0.50 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
36.16 %
36.05 %
36.33 %
36.14 %
35.59 %
35.87 %
35.90 %
39.27 %
7.27 %
38.75 %
38.99 %
38.87 %
39.10 %
38.96 %
39.76 %
39.98 %
No of Share Holders
0
4,136
4,567
5,394
5,750
6,034
6,232
5,968
6,555
6,561
7,019
6,894
7,005
7,044
7,709
7,915

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 20, 2025, 10:44
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jan 02, 2025, 19:14
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 31, 2024, 10:15
View more

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,742.50 4,18,084.12 35.94 49,887.20 12.06 9,648 13.77 47.04
Divis Laboratories
6,136.90 1,62,915.41 78.25 8,184.00 0.89 1,600 64.53 59.36
Cipla
1,441.50 1,16,417.56 23.45 26,520.70 14.17 4,155 47.38 49.10
Torrent Pharmaceuticals
3,128.00 1,05,865.73 56.43 10,785.70 11.59 1,656 13.54 34.52
Mankind Pharma
2,515.00 1,03,760.58 51.56 10,615.60 19.57 1,942 -16.38 46.81
Dr Reddys Laboratories
1,224.05 1,02,136.06 18.95 28,905.40 12.36 5,578 1.69 38.90
Lupin
2,184.70 99,665.48 36.66 20,141.50 19.94 1,936 73.53 48.22
Zydus Life Science
967.70 97,373.26 22.90 19,831.50 13.82 3,831 14.57 51.14
Aurobindo Pharma
1,203.50 69,899.48 18.82 29,559.20 17.55 3,169 8.66 45.72
Alkem Laboratories
5,142.55 61,486.90 28.08 12,978.40 9.84 1,812 14.16 42.91

Corporate Action

Technical Indicators

RSI(14)
Neutral
40.33
ATR(14)
Less Volatile
5.49
STOCH(9,6)
Neutral
25.57
STOCH RSI(14)
Neutral
21.76
MACD(12,26)
Bearish
-0.08
ADX(14)
Weak Trend
10.59
UO(9)
Bearish
36.85
ROC(12)
Downtrend And Accelerating
-2.74
WillR(14)
Oversold
-87.80
Bearish
4
Neutral
5
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Candlestick Screeners
Technical Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.